Amundi’s MiMedx Group MDXG Stock Holding History

Amundi’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,434	Closed	-$63K	–	1690
2021 Q4	$63K	Hold	12,434	–	–	﹤0.01%	1600
2021 Q3	$75K	Buy	+12,434	New	+$140K	﹤0.01%	1522

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BMO

Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return

Amundi's MDXG Position: Q1 2022 in Review

Amundi sold out of MiMedx Group (MDXG) in Q1 2022, closing a stake of 12,434 shares — an estimated $63K sold.

Amundi first reported a position in MDXG in Q3 2021 and held it in 2 quarters. The position peaked at $75K in Q3 2021. 150 funds tracked by Wall St. Rank hold MDXG as of Q1 2022.

Amundi reported no remaining MiMedx Group position as of Q1 2022 after selling out during the quarter.
Amundi sold 12,434 MiMedx Group shares in Q1 2022, an estimated $63K.
Amundi first reported a position in MiMedx Group in Q3 2021 and held it in 2 quarters.
Amundi's MiMedx Group position peaked at $75K in Q3 2021.
150 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2022.

Based on Amundi's 13F filing for Q1 2022, filed 16 May 2022.